Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome

Richard Legro, Deborah Driscoll, Jerome F. Strauss, Janis Fox, Andrea Dunaif

Research output: Contribution to journalArticle

464 Citations (Scopus)

Abstract

Our preliminary family studies have suggested that some female first- degree relatives of women with polycystic ovary syndrome (PCOS) have hyperandrogenemia perse. It was our hypothesis that this may be a genetic trait and thus could represent a phenotype suitable for linkage analysis. To investigate this hypothesis, we examined 115 sisters of 80 probands with PCOS from unrelated families. PCOS was diagnosed by the combination of elevated serum androgen levels and ≤6 menses per year with the exclusion of secondary causes. The sisters were compared with 70 healthy age- and weight-comparable control women with regular menses, no clinical evidence of hyperandrogenemia, and normal glucose tolerance. Twenty-two percent of the sisters fulfilled diagnostic criteria for PCOS. In addition, 24% of the sisters had hyperandrogenemia and regular menstrual cycles. Circulating testosterone (T) and nonsex hormone-binding globulin-bound testosterone (uT) levels in both of these groups of sisters were significantly increased compared with unaffected sisters and control women (P < 0.0001 for both T and uT). Probands, sisters with PCOS, and hyperandrogenemic sisters had elevated serum luteinizing hormone levels compared with control women. We conclude that there is familial aggregation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds. In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of PCOS, whereas the remaining one-half have hyperandrogenemia per se. This familial aggregation of hyperandrogenemia in PCOS kindreds suggests that it is a genetic trait. We propose that hyperandrogenemia be used to assign affected status in linkage studies designed to identify PCOS genes.

Original languageEnglish (US)
Pages (from-to)14956-14960
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number25
DOIs
StatePublished - Dec 8 1998

Fingerprint

Polycystic Ovary Syndrome
Siblings
Oligomenorrhea
Menstruation
Testosterone
Globulins
Menstrual Cycle
Luteinizing Hormone
Serum
Androgens
Hormones
Phenotype
Weights and Measures
Glucose

All Science Journal Classification (ASJC) codes

  • General

Cite this

Legro, Richard ; Driscoll, Deborah ; Strauss, Jerome F. ; Fox, Janis ; Dunaif, Andrea. / Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. In: Proceedings of the National Academy of Sciences of the United States of America. 1998 ; Vol. 95, No. 25. pp. 14956-14960.
@article{9ee2665fc9e441db9e23d145ff5e6f4e,
title = "Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome",
abstract = "Our preliminary family studies have suggested that some female first- degree relatives of women with polycystic ovary syndrome (PCOS) have hyperandrogenemia perse. It was our hypothesis that this may be a genetic trait and thus could represent a phenotype suitable for linkage analysis. To investigate this hypothesis, we examined 115 sisters of 80 probands with PCOS from unrelated families. PCOS was diagnosed by the combination of elevated serum androgen levels and ≤6 menses per year with the exclusion of secondary causes. The sisters were compared with 70 healthy age- and weight-comparable control women with regular menses, no clinical evidence of hyperandrogenemia, and normal glucose tolerance. Twenty-two percent of the sisters fulfilled diagnostic criteria for PCOS. In addition, 24{\%} of the sisters had hyperandrogenemia and regular menstrual cycles. Circulating testosterone (T) and nonsex hormone-binding globulin-bound testosterone (uT) levels in both of these groups of sisters were significantly increased compared with unaffected sisters and control women (P < 0.0001 for both T and uT). Probands, sisters with PCOS, and hyperandrogenemic sisters had elevated serum luteinizing hormone levels compared with control women. We conclude that there is familial aggregation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds. In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of PCOS, whereas the remaining one-half have hyperandrogenemia per se. This familial aggregation of hyperandrogenemia in PCOS kindreds suggests that it is a genetic trait. We propose that hyperandrogenemia be used to assign affected status in linkage studies designed to identify PCOS genes.",
author = "Richard Legro and Deborah Driscoll and Strauss, {Jerome F.} and Janis Fox and Andrea Dunaif",
year = "1998",
month = "12",
day = "8",
doi = "10.1073/pnas.95.25.14956",
language = "English (US)",
volume = "95",
pages = "14956--14960",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "25",

}

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. / Legro, Richard; Driscoll, Deborah; Strauss, Jerome F.; Fox, Janis; Dunaif, Andrea.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 25, 08.12.1998, p. 14956-14960.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome

AU - Legro, Richard

AU - Driscoll, Deborah

AU - Strauss, Jerome F.

AU - Fox, Janis

AU - Dunaif, Andrea

PY - 1998/12/8

Y1 - 1998/12/8

N2 - Our preliminary family studies have suggested that some female first- degree relatives of women with polycystic ovary syndrome (PCOS) have hyperandrogenemia perse. It was our hypothesis that this may be a genetic trait and thus could represent a phenotype suitable for linkage analysis. To investigate this hypothesis, we examined 115 sisters of 80 probands with PCOS from unrelated families. PCOS was diagnosed by the combination of elevated serum androgen levels and ≤6 menses per year with the exclusion of secondary causes. The sisters were compared with 70 healthy age- and weight-comparable control women with regular menses, no clinical evidence of hyperandrogenemia, and normal glucose tolerance. Twenty-two percent of the sisters fulfilled diagnostic criteria for PCOS. In addition, 24% of the sisters had hyperandrogenemia and regular menstrual cycles. Circulating testosterone (T) and nonsex hormone-binding globulin-bound testosterone (uT) levels in both of these groups of sisters were significantly increased compared with unaffected sisters and control women (P < 0.0001 for both T and uT). Probands, sisters with PCOS, and hyperandrogenemic sisters had elevated serum luteinizing hormone levels compared with control women. We conclude that there is familial aggregation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds. In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of PCOS, whereas the remaining one-half have hyperandrogenemia per se. This familial aggregation of hyperandrogenemia in PCOS kindreds suggests that it is a genetic trait. We propose that hyperandrogenemia be used to assign affected status in linkage studies designed to identify PCOS genes.

AB - Our preliminary family studies have suggested that some female first- degree relatives of women with polycystic ovary syndrome (PCOS) have hyperandrogenemia perse. It was our hypothesis that this may be a genetic trait and thus could represent a phenotype suitable for linkage analysis. To investigate this hypothesis, we examined 115 sisters of 80 probands with PCOS from unrelated families. PCOS was diagnosed by the combination of elevated serum androgen levels and ≤6 menses per year with the exclusion of secondary causes. The sisters were compared with 70 healthy age- and weight-comparable control women with regular menses, no clinical evidence of hyperandrogenemia, and normal glucose tolerance. Twenty-two percent of the sisters fulfilled diagnostic criteria for PCOS. In addition, 24% of the sisters had hyperandrogenemia and regular menstrual cycles. Circulating testosterone (T) and nonsex hormone-binding globulin-bound testosterone (uT) levels in both of these groups of sisters were significantly increased compared with unaffected sisters and control women (P < 0.0001 for both T and uT). Probands, sisters with PCOS, and hyperandrogenemic sisters had elevated serum luteinizing hormone levels compared with control women. We conclude that there is familial aggregation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds. In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of PCOS, whereas the remaining one-half have hyperandrogenemia per se. This familial aggregation of hyperandrogenemia in PCOS kindreds suggests that it is a genetic trait. We propose that hyperandrogenemia be used to assign affected status in linkage studies designed to identify PCOS genes.

UR - http://www.scopus.com/inward/record.url?scp=0032428506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032428506&partnerID=8YFLogxK

U2 - 10.1073/pnas.95.25.14956

DO - 10.1073/pnas.95.25.14956

M3 - Article

C2 - 9843997

AN - SCOPUS:0032428506

VL - 95

SP - 14956

EP - 14960

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 25

ER -